Wuhan Hiteck Biological Pharma Co.,Ltd (SHE:300683)

SHE:300683 Revenue

Wuhan Hiteck Biological Pharma Co.,Ltd had revenue of 66.47M CNY in the quarter ending June 30, 2026, a decrease of -43.86%. This brings the company's revenue in the last twelve months to 491.90M, down -23.07% year-over-year. In the year 2025, Wuhan Hiteck Biological Pharma Co.,Ltd had annual revenue of 541.45M, down -16.57%.

• Revenue (ttm): 491.90M
• Revenue Growth: -23.07%
• P/S Ratio: 6.51
• Revenue / Employee: n/a
• Employees: 958
• Market Cap: 3.20B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	541.45M	-107.52M	-16.57%
Dec 31, 2024	648.97M	46.69M	7.75%
Dec 31, 2023	602.28M	-86.34M	-12.54%
Jan 1, 2023	688.63M	73.94M	12.03%
Jan 1, 2022	614.68M	90.56M	17.28%

Data Source: S&P Global Market Intelligence Last updated: Aug 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error